While you’re creating products – we’ll keep an eye on your customers…

...then we’ll work together to best address their needs.

To quote Dr. Hamburg, FDA Commissioner (June 22, 2010),
‘focus on outcomes for individuals...honing in on the value...’

Click below for more information

• Home
• Verification/
  Adherence Programs
• Risk Management
• Safety Surveillance
• Pharmacovigilance
• Personalized Medicine
• CER
• REMS
• RiskMAPS
• Pain Management Surveillance
• Patient Registry
• Outcomes Research
• Forecasting-Formulary,
  OTC and DTC
• Competitive Identification and Targeting
• Communications Planning/Strategy
• Testing and Validation
• What We Do
• Contact Us

RiskMAPS

M/A/R/C Rx can work with sponsors to determine the effectiveness of the RiskMAPS through patient monitoring and surveillance. Vigilant patient monitoring is key to a long term effective RiskMAPS.

To request more information, click here.